Global EditionASIA 中文双语Français
China
Home / China / Latest

China confirms cooperation with Canada on drugs, vaccines development against COVID-19

Xinhua | Updated: 2020-05-13 20:01
Share
Share - WeChat

BEIJING -- China is actively conducting international cooperation with world countries including Canada in drugs and vaccines development against COVID-19, according to a Foreign Ministry spokesperson Wednesday.

Spokesperson Zhao Lijian made the remarks at a routine press briefing in Beijing when asked to comment on media reports that Canada's National Research Council said on Tuesday that Canada is collaborating with China's CanSino Biologics Inc. to pave the way for future trials of candidate vaccines in the country. The Chinese company is going to submit applications for clinical trials to Health Canada.

Commenting on the health cooperation between China and Canada, Zhao said the two sides have been giving mutual support and help since the outbreak of the pandemic. "The 32 tonnes of medical supplies donated by the Chinese government have been shipped to Canada, and we have been offering active assistance and convenience for the Canadian side to purchase medical supplies here."

Virus respects no borders and is the common challenge faced by all humankind, Zhao said, adding vaccine development is vital to the pandemic prevention and control, and the key to the success in the fight against COVID-19.

China is actively conducting international cooperation with world countries including Canada in drugs and vaccines development, and is ready to work with Canada and the international community in expediting the development and production of medical items against COVID-19, to contribute to safeguarding global public health security and to fight the pandemic, Zhao added.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US